Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15841482 | 1.00 | TSHR (0.53) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL1832088 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL19127751 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL29709585 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL7148974 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL12904430 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL11059297 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL265598 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL17887907 | 0.91 | TSHR (0.50) | TSHRTP53CYP2C9PDE4AALDH1A1 | |
| SCHEMBL28773455 | 0.88 | PDE4A (0.48) | TSHRTP53CYP2C9PDE4AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116585369-A | Method for extracting mung bean flavone by ultrasonic-assisted eutectic solvent | 中国农业大学 | 2023-08-15 | — | — | CN | claimed |
| CN-114752939-A | Etching solution and preparation method and application thereof | 光华科学技术研究院(广东)有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-101260248-B | Novel method for increasing solubility of medium black P2B dyestuff | LIAONING PREC CHEMICAL TECHNOLOGY CO LTD | 2011-05-18 | — | — | CN | claimed |
| CN-101260248-A | Novel method for increasing solubility of medium black P2B dyestuff | LIAONING PREC CHEMICAL TECHNOL (CN) | 2008-09-10 | — | — | CN | claimed |
| US-20250127925-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | HERCULES CAPITAL, INC. | 2025-04-24 | — | — | US | disclosed |
| US-12076418-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | ENGENE, INC. (CA) | 2024-09-03 | — | — | US | disclosed |
| CN-114752939-B | Etching solution and preparation method and application thereof | 光华科学技术研究院(广东)有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-116585369-A | Method for extracting mung bean flavone by ultrasonic-assisted eutectic solvent | 中国农业大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-114752939-A | Etching solution and preparation method and application thereof | 光华科学技术研究院(广东)有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-20220133907-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | HERCULES CAPITAL, INC. | 2022-05-05 | — | — | US | disclosed |
| EP-3970697-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | Engene, Inc. (CA) | 2022-03-23 | — | — | EP | disclosed |
| US-11167045-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | HERCULES CAPITAL, INC. | 2021-11-09 | — | — | US | disclosed |
| US-20120021468-A1 | PRODUCTION OF L-RIBOSE AND OTHER RARE SUGARS | ZUCHEM, INC. (US) | 2012-01-26 | — | — | US | disclosed |
| EP-2396009-A1 | COMPOSITIONS FOR THE TREATMENT OF APHTHOUS STOMATITIS | Bonucci, Monica (IT) | 2011-12-21 | — | — | EP | disclosed |
| CN-101260248-B | Novel method for increasing solubility of medium black P2B dyestuff | LIAONING PREC CHEMICAL TECHNOLOGY CO LTD | 2011-05-18 | — | — | CN | disclosed |
| US-20100267757-A1 | AMINOTHIAZOLES AND THEIR USES | NOVARTIS AG (CH) | 2010-10-21 | — | — | US | disclosed |
| WO-2010092534-A1 | COMPOSITIONS FOR THE TREATMENT OF APHTHOUS STOMATITIS | BONUCCI MONICA (IT) | 2010-08-19 | — | — | WO | disclosed |
| CN-101260248-A | Novel method for increasing solubility of medium black P2B dyestuff | LIAONING PREC CHEMICAL TECHNOL (CN) | 2008-09-10 | — | — | CN | disclosed |
| US-5017663-A | Polyphenylene ether, polyamide blend | SUMITOMO CHEMICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4448912-A | QUATERNIZATION WITH PRIMARY AND/OR SECONDARY AMINE AND ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267757-A1 | AMINOTHIAZOLES AND THEIR USES | ABAT, AADAT, GOT2 | TSHR 2485/4885TP53 635/4885CYP2C9 943/4885 |
| US-20250127925-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | CSGALNACT1, CHI3L2, LNPEP | TSHR 4331/4885TP53 1908/4885CYP2C9 4006/4885 |
| US-11167045-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | CSGALNACT1, CHI3L2, LNPEP | TSHR 4331/4885TP53 1908/4885CYP2C9 4006/4885 |
| US-12076418-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | CSGALNACT1, CHI3L2, LNPEP | TSHR 4331/4885TP53 1908/4885CYP2C9 4006/4885 |
| US-20220133907-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | CSGALNACT1, CHI3L2, LNPEP | TSHR 4331/4885TP53 1908/4885CYP2C9 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.